NASDAQ:ATRA

Atara Biotherapeutics Stock Insider Trading

etoro logo Buy ATRA
*Your capital is at risk
$9.63
-0.270 (-2.73%)
At Close: Jun 03, 2026

Atara Biotherapeutics Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 54.67. In total, the insiders bought 9.54M and sold 448.96K ATRA shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
54.67
Buy 9.54M shares
Sell 448.96K shares
50% Buy Activity
Negligible or No Correlation
Sell Signal Low Confidence
May 07, 2026

Analysis Breakdown:

  • Signal is highly questionable due to a strongly contradictory positive Insider Power Score of 54.67.
  • Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date Type Person Role Amount
Nov 17, 2025
Sell
Common Stock
S-Sale
Grant-huerta Yanina
Chief Accounting Officer
Officer 85
Value: $1K
Nov 17, 2025
Sell
Common Stock
S-Sale
Grant-huerta Yanina
Chief Accounting Officer
Officer 74
Value: $976
Aug 18, 2025
Sell
Common Stock
S-Sale
Nguyen Anhco
President And CEO
CEO / President 57
Value: $662
Aug 18, 2025
Sell
Common Stock
S-Sale
Nguyen Anhco
President And CEO
CEO / President 1 281
Value: $14.9K
Aug 18, 2025
Sell
Common Stock
S-Sale
Nguyen Anhco
President And CEO
CEO / President 1 620
Value: $18.8K
Aug 18, 2025
Sell
Common Stock
S-Sale
Grant-huerta Yanina
Chief Accounting Officer
Officer 55
Value: $638
Aug 18, 2025
Sell
Common Stock
S-Sale
Grant-huerta Yanina
Chief Accounting Officer
Officer 86
Value: $999
Aug 18, 2025
Sell
Common Stock
S-Sale
Grant-huerta Yanina
Chief Accounting Officer
Officer 1 668
Value: $19.4K
Aug 18, 2025
Sell
Common Stock
S-Sale
Grant-huerta Yanina
Chief Accounting Officer
Officer 1 668
Value: $19.4K
Aug 18, 2025
Sell
Common Stock
S-Sale
Grant-huerta Yanina
Chief Accounting Officer
Officer 86
Value: $999
Aug 18, 2025
Sell
Common Stock
S-Sale
Grant-huerta Yanina
Chief Accounting Officer
Officer 55
Value: $638
Aug 18, 2025
Sell
Common Stock
S-Sale
Nguyen Anhco
President And CEO
CEO / President 1 620
Value: $18.8K
Aug 18, 2025
Sell
Common Stock
S-Sale
Nguyen Anhco
President And CEO
CEO / President 1 281
Value: $14.9K
Aug 18, 2025
Sell
Common Stock
S-Sale
Nguyen Anhco
President And CEO
CEO / President 57
Value: $662
Aug 15, 2025
Buy
Common Stock
P-Purchase
Panacea Innovation Ltd
10 Percent Owner
10% Owner 55 000
Value: $670.4K
Aug 15, 2025
Buy
Common Stock
P-Purchase
Panacea Innovation Ltd
10 Percent Owner
10% Owner 55 000
Value: $670.4K
Jul 17, 2025
Buy
Common Stock
P-Purchase
Panacea Innovation Ltd
10 Percent Owner
10% Owner 19 335
Value: $186.4K
Jul 17, 2025
Buy
Common Stock
P-Purchase
Panacea Innovation Ltd
10 Percent Owner
10% Owner 19 335
Value: $186.4K
Jun 10, 2025
Buy
Common Stock
A-Award
Gallagher Carol Giltner
Director
Director 7 828
Value: $71.4K
Jun 10, 2025
Buy
Common Stock
A-Award
Fust Matthew K
Director
Director 7 828
Value: $71.4K
Jun 10, 2025
Buy
Common Stock
A-Award
Touchon Pascal
Director
Director 7 828
Value: $71.4K
Jun 10, 2025
Buy
Common Stock
A-Award
Roncarolo Maria Grazia
Director
Director 7 828
Value: $71.4K
Jun 10, 2025
Buy
Common Stock
A-Award
Mallik Ameet
Director
Director 7 828
Value: $71.4K
Jun 10, 2025
Buy
Common Stock
A-Award
Heiden William K
Director
Director 7 828
Value: $71.4K
Jun 10, 2025
Buy
Common Stock
A-Award
Heiden William K
Director
Director 7 828
Value: $71.4K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT ATARA BIOTHERAPEUTICS
Atara Biotherapeutics
Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferative disease, as well as hematologic and solid tumors, including nasopharyngeal carcinoma. The company i...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE